After notification of any recall, Express Scripts will continue processing new and refill prescriptions with product from non-recalled lots or manufacturers, if available. Please visit the U.S. Food and Drug Administration (FDA) website for the most up-to-date information on drug safety and recalls.
Yimmugo Lots Withdrawn
August 28, 2026
Biotest AG initiated a voluntary withdrawal for certain lots of Yimmugo® (immune globulin IV, human-dira), 10% liquid, on Aug. 13, 2026.
On Aug. 12, 2026, Grifols Therapeutics initiated a voluntary withdrawal of one lot of Gamunex®-C (immune globulin injection [human], 10%), 40g/400mL vial.
On July 30, 2026, GC Biopharma Corporation initiated a voluntary market withdrawal for three lots of Alyglo® (immune globulin intravenous, human-stwk) 10% Liquid.
On July 24, 2026, Baxter International Inc. initiated a voluntary recall of cefazolin in dextrose injection, USP, 2g/100mL (20mg/mL), single-dose infusion bag, 100mL.
Haleon Issues Voluntary Recall of Gas-X Extra Strength Softgels Due to Potential Contamination
June 12, 2026
On June 4, 2026, Haleon announced a voluntary recall of its Gas X Extra Strength Softgels (simethicone) 125mg due to potential chemical contamination during packaging affecting select lots.
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.